PTC Therapeutics (NASDAQ:PTCT) has been coming along well as a biotech since it had received FDA approval of SEPHIENCE [sepiapterin] for the treatment of children and adults with phenylketonuria [PKU] ...

PayPal's Q2 results shine with strong EPS growth, operational leverage, and promising initiatives like Pay with Crypto. Read the latest analysis on the stock here.

UPS faces declining revenues, margin pressure, and union resistance, but $82 offers a compelling long-term entry point for ...

Toyota Motor Corporation faces short-term pressures from tariffs, costs, and weak U.S. demand. Click for the long-term ...

Discover how Jerome Powell's Jackson Hole speech could redefine US interest rates, impact inflation targets, and shape ...

Anthropic now allows subscribers of its Enterprise and Teams plans to add premium seats that include Claude Code, an ...

Target beat Q2 earnings, revenue, and same-store sales expectations, but underlying challenges remain. Click to read.

In July, export prices in yen terms of passenger cars shipped to North America rose 2.2% from June to mark the first month-over-month rise increase in six months. Even on a contract-currency basis, ...

However, the market has what I'd refer to as a "sick puppy" problem. It has a kennel full of them, in fact. That is, so many ...

Adecoagro S.A.'s 1H25 shows weak results due to low prices and yields. Click for my AGRO earnings update and a close look a ...

On Holding's recent stock decline is due to market rotation, not fundamentals, creating a compelling entry point for ...

Ballard Power Systems Inc.'s Q2 results lag expectations with weak orders and high cash burn. Click for how BLDP aims for ...